Publications by authors named "Nancy Janiczek"

Claim this Profile
A
A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin.
Howard N Bockbrader, David Wesche, Raymond Miller, Sunny Chapel, Nancy Janiczek

Clin Pharmacokinet· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitor.
Jeffrey T Kohrt, Christopher F Bigge, John W Bryant, Agustin Casimiro-Garcia, Liguo Chi, Nancy Janiczek

Chem Biol Drug Des· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors.
Chad A Van Huis, Christopher F Bigge, Agustin Casimiro-Garcia, Wayne L Cody, Danette A Dudley, Nancy Janiczek

Chem Biol Drug Des· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation modifications of PD 0313052, a direct Factor Xa Inhibitor, alter pharmacokinetics and pharma-codynamics following subcutaneous administration to rabbits.
Yun-Wen Peng, Liguo Chi, Glenn Gibson, Nancy Janiczek, Paul Juneau

J Pharm Pharm Sci· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of glycine and related amino acid-based factor Xa inhibitors.
Jeffrey T Kohrt, Kevin J Filipski, Wayne L Cody, Christopher F Bigge, Frances La, Nancy Janiczek

Bioorg Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo antithrombotic activity of PD-198961, a novel synthetic factor Xa inhibitor.
Liguo Chi, Yun-Wen Peng, Glenn Gibson, Gary Hicks, Thomas E Mertz, Nancy Janiczek

J Cardiovasc Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of ex vivo pharmacodynamic markers during inhibition of thrombosis by CI-1031 (ZK-807834), a novel direct factor Xa inhibitor.
Liguo Chi, Yun-Wen Pen, Ronald Potoczak, Glenn Gibson, Gary Hicks, Nancy Janiczek

Pharmacology· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis